Vascular Biogenics Ltd (VBLT)

[Oren1976]

The way I understand it. Correct me why I m wrong. The fda see that if it has to do futility interim the recommendation will be to stop the trial because vb111 is doing the same as avastin. Because the fda wants to help vbl pass this trial (like they did with avastin approving although useless) they want to give it more chance and more time . The fda probably know the cliff phenomenon in avastin and maybe they believe this cliff didn't arrive yet they want to cancel futility to give vbl a chance. I saw it bad news from the beginning and I still think it's bad news although the market think different. People here and other forums feel different. And except the girl that asked him in conference call suspecting there is more to the story that for hides nobody suspected a thing while this girl and me suspect. The girl asked " is there anything beyond that which u don't share with us "